WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 6701 Infant (under 12 months) mortality rate: 802
GDP / capita (US$): 1'6411 Child (under 5 years) mortality rate: 1282

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 15'302  14'854  14'417  13'986  13'559  10'261  7'964  6'735 
Births 723  705  687  668  650  496  384  331 
Surviving infants 661  643  624  606  587  440  333  279 
Pop. less than 5 years 2'951  2'865  2'774  2'675  2'592  1'919  1'468  1'203 
Pop. less than 15 years 7'252  7'018  6'783  6'545  6'341  4'730  3'690  2'927 
Female 15-49 years 3'344  3'251  3'164  3'081  2'986  2'260  1'726  1'513 

Number of reported case

(Click for retrospective incidence data for Mali)
Diphtheria 143 
Japanese encephalitis
Measles 221  341  24  1'719  2'939  1'578  1'388  10'007 
Mumps
Pertussis 430  2'811 
Polio* 63  234 
Rubella 19  19  125  64 
Rubella (CRS)
Tetanus (neonatal) 12  10  11  13  73  203 
Tetanus (total) 37  108  86  73  168  365  294 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Mali)
Vaccine year result method % card seen                                                
BCG 2009  84  MICS   59  89  99*  100  97  81  82  82 
DTP1 2009  82  MICS   59  86  99*  99*  99*  61 
DTP3 2009  72  MICS   59  76  90  88  92  89  54  42 
HepB_BD         
HepB3 2009  27  MICS   59  76  90  88  92  89 
Hib3 2008  75  EPI   65  76  90  88  92  89 
JapEnc         
MCV 2009  73  MICS   59  72  85  82  89  86  55  43 
MCV2         
PCV1          86  99*  99* 
PCV3          76  87  56 
Pol3 2009  62  MICS   59  79  90  87  89  86  54  42 
Rota1         
Rota_last         
Rubella1         
TT2plus 2008  47  MICS   59  95  66  60  59  61  62  37 
PAB         
VAD1          73 
YFV 2009  72  MICS   59  75  84  81  88  85 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Mali)
BCG 87  87  87  84  84  69  82 
DTP1 82  82  82  82  82  61  67 
DTP3 74  74  72  76  73  43  42 
HepB3 74  74  72  76  73 
HepB_BD
Hib3 74  74  72  76  73 
MCV 72  72  69  76  73  49  43 
MCV2
PAB 85  89  89  85  92  50  45 
PCV3 74  74  56 
Pol3 81  81  78  80  77  53  42 
Rota_last
YFV 62  71  68  75  72  11 

Number of districts in the country 60  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
97 
   
/
|
|
\
Greater or equal to 90% 58
From 80 to 89% 18
From 50 to 79% 10
Less than 50% 13
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV No From October 2014
Measles 9 months; Yes
OPV 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10, 14 weeks; No
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
VitaminA 6 months; Yes From April 2014
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016  2007-2011  2007-2011  2007 - 2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 60  60    59  59  59  26 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No    No       

System performance

Total Nº districts in country number 60  60  60  59  59  59  59 
Nº districts with DTP3 coverage >=80% number 46  44  43  42  48  48  10 
% of districts with DTP3 coverage >=80% From 0 to 100% 77  73  72  71  81  81  17 
Nº districts with measles (MCV1) coverage >=95% number 17  15  10  18  34  36   
% of districts with MCV1 coverage >=95% From 0 to 100% 28  25  17  31  58  61   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 14  12    20  100  20  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.